Rixin Chen

2.0k total citations · 1 hit paper
33 papers, 910 citations indexed

About

Rixin Chen is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Rixin Chen has authored 33 papers receiving a total of 910 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 14 papers in Molecular Biology and 13 papers in Surgery. Recurrent topics in Rixin Chen's work include Esophageal Cancer Research and Treatment (9 papers), RNA modifications and cancer (9 papers) and Lung Cancer Diagnosis and Treatment (7 papers). Rixin Chen is often cited by papers focused on Esophageal Cancer Research and Treatment (9 papers), RNA modifications and cancer (9 papers) and Lung Cancer Diagnosis and Treatment (7 papers). Rixin Chen collaborates with scholars based in China, Hong Kong and United Kingdom. Rixin Chen's co-authors include Dan Xie, Feng‐Wei Wang, Kai Han, Jiewei Chen, Xin Chen, Liangping Xia, Feng Wang, Jing‐Ping Yun, Olivier Déas and Rui‐Hua Xu and has published in prestigious journals such as Nature Communications, Scientific Reports and Molecular Cancer.

In The Last Decade

Rixin Chen

26 papers receiving 907 citations

Hit Papers

N6-methyladenosine modification of circNSUN2 facilitates ... 2019 2026 2021 2023 2019 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. N6-methyladenosine modification of circNSUN2 facilitates cytoplasmic export and stabilizes HMGA2 to promote colorectal liver metastasis
    2019 537 citations Rixin Chen, Zhizhong Pan et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rixin Chen China 11 810 588 92 49 47 33 910
Stella Paffenholz United States 4 616 0.8× 543 0.9× 21 0.2× 40 0.8× 39 0.8× 4 705
Junhao Zheng China 9 292 0.4× 223 0.4× 62 0.7× 61 1.2× 17 0.4× 30 492
Ivan A. Zaporozhchenko Russia 15 539 0.7× 477 0.8× 90 1.0× 48 1.0× 31 0.7× 26 653
Genpeng Li China 13 280 0.3× 190 0.3× 48 0.5× 59 1.2× 53 1.1× 36 565
Nina Gennebäck Sweden 3 405 0.5× 226 0.4× 22 0.2× 16 0.3× 37 0.8× 4 442
Erika Larrea Spain 6 283 0.3× 259 0.4× 64 0.7× 34 0.7× 25 0.5× 8 362
Youhei Tanaka Japan 4 568 0.7× 500 0.9× 53 0.6× 78 1.6× 30 0.6× 8 676
Zhengming Zhu China 14 273 0.3× 223 0.4× 44 0.5× 48 1.0× 25 0.5× 23 395
Ann Kurian India 10 305 0.4× 113 0.2× 29 0.3× 97 2.0× 18 0.4× 26 517
Wentong Mei China 9 346 0.4× 233 0.4× 20 0.2× 86 1.8× 42 0.9× 24 470

Countries citing papers authored by Rixin Chen

Since Specialization
Citations

This map shows the geographic impact of Rixin Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rixin Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rixin Chen more than expected).

Fields of papers citing papers by Rixin Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rixin Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rixin Chen. The network helps show where Rixin Chen may publish in the future.

Co-authorship network of co-authors of Rixin Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Rixin Chen. A scholar is included among the top collaborators of Rixin Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rixin Chen. Rixin Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Chen, Rixin, Jianguo Wu, Minhua Deng, et al.. (2025). m6A-mediated circG3BP1 translocation to stress granules promotes nucleation and senescence-linked chemoresistance. Cell Reports. 44(10). 116375–116375.
3.
Wu, Junhan, Weitao Zhuang, Rixin Chen, et al.. (2025). Impact of surgery versus follow-up on psychological distress in patients with indeterminate pulmonary nodules: A prospective observational study. Quality of Life Research. 34(4). 1167–1177.
4.
Yu, Bin, Yuanyuan Zhou, Wenqiang Huang, et al.. (2025). Sintilimab combined with acetaminophen aggravates liver injury through apoptotic and disturbed bile acid pathways. Toxicology. 514. 154106–154106. 1 indexed citations
5.
Chen, Rixin, Minhua Deng, Jiewei Chen, et al.. (2024). Mex-3 RNA binding family member A (MEX3A)/circMPP6 complex promotes colorectal cancer progression by inhibiting autophagy. Signal Transduction and Targeted Therapy. 9(1). 80–80. 13 indexed citations
6.
Ma, Xiaodan, Li Xu, Jingdun Xie, et al.. (2024). Dual specific phosphatase 4 suppresses ferroptosis and enhances sorafenib resistance in hepatocellular carcinoma. Drug Resistance Updates. 73. 101052–101052. 31 indexed citations
7.
8.
Li, Zijie, Shujie Huang, Rixin Chen, et al.. (2024). Association Between Treatment-Related Adverse Event Trajectory and Prognosis in Esophageal Cancer Receiving Neoadjuvant Immunochemotherapy. Annals of Surgical Oncology. 32(6). 4173–4180.
9.
Xiang, Leihong, Rixin Chen, Liming Wu, et al.. (2024). 49342 First FASN inhibitor ASC40 to treat acne vulgaris patients: final results form a Phase 2 trial. Journal of the American Academy of Dermatology. 91(3). AB217–AB217. 3 indexed citations
10.
Liu, Songlin, Shaopeng Li, Yong Tang, Rixin Chen, & Guibin Qiao. (2023). Minimally invasive surgery vs. open thoracotomy for non-small-cell lung cancer with N2 disease: a systematic review and meta-analysis. Frontiers in Medicine. 10. 1152421–1152421. 6 indexed citations
11.
12.
Huang, Shujie, Yong Tang, Qiuling Shi, et al.. (2023). Early and Persistent Dysphagia Relief Predicts Tumor Response in Esophageal Squamous Cell Carcinoma Patients Treated with Immunochemotherapy. Annals of Surgical Oncology. 30(8). 5171–5181. 2 indexed citations
13.
Duan, Jin‐Ling, Wei Chen, Juanjuan Xie, et al.. (2022). A novel peptide encoded by N6-methyladenosine modified circMAP3K4 prevents apoptosis in hepatocellular carcinoma. Molecular Cancer. 21(1). 93–93. 109 indexed citations
14.
Zhang, Jingyu, Weitao Zhuang, Zhen Gao, et al.. (2022). Improving the efficiency of identifying malignant pulmonary nodules before surgery via a combination of artificial intelligence CT image recognition and serum autoantibodies. European Radiology. 33(5). 3092–3102. 10 indexed citations
15.
16.
Ben, Xiaosong, Dan Tian, Weitao Zhuang, et al.. (2022). Accuracy of next-generation sequencing for molecular profiling of small specimen of lung cancer: a prospective pilot study of side-by-side comparison. Diagnostic Pathology. 17(1). 78–78. 2 indexed citations
17.
Zhuang, Weitao, Rixin Chen, Xiaosong Ben, et al.. (2022). The staging performance of a modified tumor-node-metastasis staging system incorporated with lymphovascular invasion in patients with esophageal squamous cell carcinoma. Frontiers in Oncology. 12. 1018827–1018827. 1 indexed citations
18.
Deng, Minhua, Ning Wang, Zhiyong Li, et al.. (2022). FXR1 can bind with the CFIm25/CFIm68 complex and promote the progression of urothelial carcinoma of the bladder by stabilizing TRAF1 mRNA. Cell Death and Disease. 13(2). 170–170. 18 indexed citations
19.
Zhuang, Weitao, Shujie Huang, Xueting Guan, et al.. (2021). Optimal Range of Lymphadenectomy in Pathological Stage T1 and T2 Esophageal Squamous Cell Carcinoma. Frontiers in Oncology. 11. 619556–619556. 1 indexed citations
20.
Han, Kai, Feng‐Wei Wang, Chenhui Cao, et al.. (2021). Correction to: CircLONP2 enhances colorectal carcinoma invasion and metastasis through modulating the maturation and exosomal dissemination of microRNA-17. Molecular Cancer. 20(1). 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stella Paffenholz Breakdown of academic impact, for papers by Junhao Zheng Breakdown of academic impact, for papers by Ivan A. Zaporozhchenko Breakdown of academic impact, for papers by Genpeng Li Breakdown of academic impact, for papers by Nina Gennebäck Breakdown of academic impact, for papers by Erika Larrea Breakdown of academic impact, for papers by Youhei Tanaka Breakdown of academic impact, for papers by Zhengming Zhu Breakdown of academic impact, for papers by Ann Kurian Breakdown of academic impact, for papers by Wentong Mei
Rankless by CCL
2026